Associated Papers
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Herencia-Ropero A et al.
Genome Medicine, 2024
39187844 (PubMed )
Supplement: 13073_2024_1370_MOESM3_ESM.xlsx › SNV
Identification of biallelic variations of CEP70 in patients with male infertility.
Ruan T et al.
Frontiers in Endocrinology, 2023
36967801 (PubMed )
Supplement: Table_2.xlsx › Patient_1
MITF variants cause nonsyndromic sensorineural hearing loss with autosomal recessive inheritance.
Thongpradit S et al.
Scientific Reports, 2020
32728090 (PubMed )
Supplement: 41598_2020_69633_MOESM1_ESM.pdf
Select a paper to view details